| Literature DB >> 35033989 |
Sajid Hameed1, Ayisha Farooq Khan1, Sara Khan1, Mohammad Wasay2.
Abstract
Cerebral venous thrombosis (CVT) is an uncommon cerebrovascular disease, which has been reported with covid infection as well as covid vaccines, particularly AstraZeneca and Janssen vaccines. We present four consecutive cases of CVT after receiving either Sinopharm or Sinovac vaccine, both of which are composed of an inactivated-virus. All the patients recovered well with anticoagulation and discharged with a good functional outcome. This is the first case series reporting CVT following the administration of these vaccines.Entities:
Keywords: CVT; Cerebral venous thrombosis; Sinopharm; Sinovac; Vaccine
Mesh:
Substances:
Year: 2022 PMID: 35033989 DOI: 10.1016/j.jstrokecerebrovasdis.2021.106298
Source DB: PubMed Journal: J Stroke Cerebrovasc Dis ISSN: 1052-3057 Impact factor: 2.136